About hemovent
hemovent is a company based in Aachen (Germany) founded in 2013 by Christof Lenz was acquired by MicroPort Orthopedics in October 2021. hemovent has raised $16.7 million across 3 funding rounds from investors including NRW.Bank, KfW and MicroPort Orthopedics. The company has 23 employees. hemovent operates in a competitive market with competitors including Belluscura, Lungpacer, ALung, Breethe and Securisyn, among others.
- Headquarter Aachen, Germany
- Employees 23
- Founders Christof Lenz
- SectorsHealthcare
- Website hemovent.com
- Social LinkedIn X
- Acquired by MicroPort Orthopedics (Oct 2021)
- Legal Name Hemovent Gmbh
- Total Equity Funding$16.7M (USD)
in 3 rounds
- Latest Funding Round$5.5M (USD), Series B
Jul 2020
- InvestorsNRW.Bank
& 5 more
- Employee Count23
- Acquired byMicroPort Orthopedics
(Oct 2021)
Funding Insights of hemovent
hemovent has successfully raised a total of $16.7M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $5.5 million completed in July 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $16.7M
- Total Rounds 3
- Last Round Series B — $5.5M
- First Round $6M
(Feb 2016)
- Investors Count 5
All 3 funding rounds of hemovent with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2020 | $5.5M | Series B | – | MIG Capital | – |
| Feb 2019 | $5.2M | Series B | – | – | – |
| Feb 2016 | $6M | Series A | – | MIG Capital |
6 investors in total: 6 institutional.
Investors in hemovent
hemovent has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include NRW.Bank, KfW and MicroPort Orthopedics.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
VC Firm funding companies in Europe | – | mig.ag | Munich, Germany | |
- | – | wctipartners.com | - | |
TechVision Fonds is engaged in early-stage venture capital investments. | 2007 | techvision-fonds.de | Aachen, Germany | |
Consumer and SME loans are provided across Germany. | 1948 | kfw.de | Frankfurt Am Main, Germany | |
Loans, advice, seminars, and networks are provided for financial support. | 2001 | nrwbank.de | Dusseldorf, Germany | |
Developer of implantable devices and diagnostic solutions for multiple fields | 1998 | microport.com | Shanghai, China |
Investor details for hemovent
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of hemovent
10 people are tracked at hemovent (2 in leadership, 8 in team); the tracked headcount is 23.
| Name | Role | Group |
|---|---|---|
Christof Lenz | Co-Founder & CEO | Leadership |
Miriam Hunds | Director of Quality and Regulatory Affairs | Leadership |
André Ronkartz | Techniker | Team |
Stefanie Bolg | Purchasing & Supply Chain Manager | Team |
Sabine Kasper | Labortechnikerin | Team |
Christina Mühlinghaus | Entwicklungsingenieurin | Team |
Thomas Schwarz | Polymer Engineering | Team |
Achim Körlings | Senior Manager Sales Germany | Team |
Jörg Hanf | Project Manager Laboratory and Service Technology | Team |
Peter Griemens | Manufacturing Engineering | Team |
Complete people profiles for hemovent
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of hemovent
4 dated milestones of hemovent across 8 years, from founding to its latest funding, stage changes and deals.
- Founded hemovent is founded.
- Funding First funding round of $6.0M.
- Funding Latest funding round, Series B, of $5.5M.
- Exit Acquired by MicroPort Orthopedics.
Competitors of hemovent
hemovent operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Belluscura, Lungpacer, ALung, Breethe and Securisyn, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| belluscura.com | 2015 | Dallas, United States | $6.38M | 21 | Provider of medical devices for laparoscopic procedures | |
| lungpacer.com | 2009 | Vancouver, Canada | $121.38M | 62 | Neurostimulation-based pacer for diaphragm strength is developed. | |
| alung.com | 1997 | Pittsburgh, United States | $132.56M | 27 | Extracorporeal CO2 removal systems are developed to supplement mechanical ventilation. | |
| breethe.com | 2014 | Montreal, Canada | – | – | Meditation programs are delivered through a mobile app by Breethe. | |
| securisyn.com | 2011 | Denver, United States | $16.79M | – | Endotracheal tube stabilization systems for ventilated patients are developed. | |
| synapsebiomedical.com | 2002 | Cleveland, United States | $1.76M | – | Neurostimulation device to treat spinal cord injury and ALS | |
| inscopemedical.com | 2014 | Louisville, United States | $1.36M | – | Laryngoscopes for intubation with wireless video and suction are provided. | |
| onebreathventilators.com | 2013 | Bengaluru, India | $3.45M | 26 | Portable mechanical ventilators for intensive care patients are developed. |
Detailed competitors of hemovent
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Hemovent
Complete news archive for hemovent
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to hemovent
10 companies that operate in the same segment as hemovent (Pulmonology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Portable oxygen concentrators are supplied for respiratory therapy needs. | 2001 | Goleta, California, United States | USD 51.65 M | USD 348.67 M | 766 | |
Cancer detection diagnostics assays are developed and offered. | 2005 | Boulder, Colorado, United States | USD 200.16 M | USD 88.5 M | 273 | |
Therapeutic devices for nasal breathing improvement are developed. | 2011 | Sunnyvale, California, United States | USD 176.4 M | – | 66 | |
Non-invasive breath-based diagnostics for cancer and infectious diseases are developed. | 2004 | Cambridge, Cambridgeshire, United Kingdom | USD 166.55 M | – | 202 | |
Protein biologics are developed for treating rare diseases. | 2005 | San Diego, California, United States | USD 171.52 M | USD 190 K | 59 | |
Therapeutics for rare respiratory diseases are developed by Savara Pharma. | 2008 | Austin, Texas, United States | USD 67.82 M | – | 59 | |
Developer of smart devices for treating pulmonary diseases | 1998 | Redwood City, California, United States | USD 280.91 M | USD 90.5 M | 291 | |
A norovirus vaccine is developed for infection prevention. | 2021 | Boston, Massachusetts, United States | USD 135 M | – | 14 | |
Oral small molecule drugs for chronic diseases are developed. | 2017 | San Francisco, California, United States | USD 233 M | – | 163 | |
Precision medicines for lung-related diseases are developed. | 2015 | Menlo Park, California, United States | USD 371 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about hemovent
hemovent was founded in 2013 and raised its 1st funding round 3 years after it was founded.
hemovent is headquartered in Aachen, Germany. It is registered at Aachen, North Rhine-westphalia, Germany.
Christof Lenz is the current CEO of hemovent. They have also founded this company.
hemovent is a funded company, having raised a total of $16.7M across 3 funding rounds to date. The company's 1st funding round was a Series A of $6M, raised on Feb 2016.
hemovent has 23 employees.
Hemovent was founded in 2013 in Aachen, Germany, within the medical devices sector. The Mobybox system, based on the Bionique technology platform, is utilized for extracorporeal life support, CO2 removal, membrane oxygenation, and artificial blood circulation. Operations center on artificial lung functions and cardiopulmonary bypass systems, with applications in critical care environments across Europe.
hemovent's top competitors include Belluscura, Lungpacer and ALung.
hemovent has 6 investors. Key investors include NRW.Bank, KfW, MicroPort Orthopedics, MIG Capital, and WCTI Partners.
hemovent operates through Hemovent Gmbh.
Yes. hemovent was acquired by MicroPort Orthopedics in October 2021.